Sigrid Therapeutics
Stockholm
About Sigrid Therapeutics
Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $37.5M
- Last round: Undisclosed (Jan 2026)
- Website: sigridthx.com
- Phone: +46723893396
Industries & Categories
Biotechnology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sigrid-therapeutics-5878 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.